Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VITASPRING BIOMEDICAL CO. LTD.

(VSBC)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2021

06/14/2021 | 04:59pm EDT

VitaSpring Biomedical Co. Ltd. announced earnings results for the first quarter ended April 30, 2021. For the first quarter, the company announced sales was USD 533,800. Net income was USD 235,662 compared to net loss of USD 17,745 a year ago.


ę S&P Capital IQ 2021
All news about VITASPRING BIOMEDICAL CO. LTD.
09/15VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
09/15Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended Ju..
CI
08/11VITASPRING BIOMEDICAL CO. LTD. : Change in Directors or Principal Officers (form 8-K)
AQ
08/11Vitaspring Biomedical Co. Ltd. Announces Management Changes
CI
06/14VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
06/14Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended Apr..
CI
04/22VITASPRING BIOMEDICAL CO. LTD. : Unregistered Sale of Equity Securities (form 8-K)
AQ
04/14VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
04/14VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January..
CI
2020Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter Ended Oct..
CI
More news
Financials (USD)
Sales 2021 0,25 M - -
Net income 2021 -0,43 M - -
Net cash 2021 0,05  - -
P/E ratio 2021 -2 570x
Yield 2021 -
Capitalization 3 118 M 3 118 M -
Capi. / Sales 2020 1 512x
EV / Sales 2021 2 936x
Nbr of Employees -
Free-Float 62,7%
Chart VITASPRING BIOMEDICAL CO. LTD.
Duration : Period :
VitaSpring Biomedical Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Cheng Hsiang Kao Chief Executive Officer & Secretary
Pao Chi Chu Chairman
Jer Li Lin Chief Technical Officer
Yen Xun Chen Vice President-Technology
Sector and Competitors
1st jan.Capi. (M$)
VITASPRING BIOMEDICAL CO. LTD.0.00%3 118
GILEAD SCIENCES, INC.21.80%88 970
BIONTECH SE315.86%81 878
WUXI APPTEC CO., LTD.35.75%69 413
REGENERON PHARMACEUTICALS32.66%66 632
VERTEX PHARMACEUTICALS-21.44%48 168